Grant Number:	5R01CA284595-03 Interpret this number
Primary Investigator:	Eisfeld, Ann-Kathrin
Organization:	Ohio State University
Project Title:	Towards an Inclusive Genomic Risk Classification for Acute Myeloid Leukemia (AML)
Fiscal Year:	2025

Acute myeloid leukemia (AML) is the most common adult acute leukemia. Molecular features such as cytogenetics and somatic mutations are essential components of risk stratification; used in daily clinical practice to determine treatment modality and intensity. Our knowledge of recurrent genetic AML-associated features, survival associations, subsequent genetic risk classification and clinical practice is informed by large-scale genomic studies performed over the past decade. Current clinical practice is predicated on the supposition that adequate testing has been performed and that genetic background should not interplay with the known AML-associated genetic and genomic landscape or with genes that associate with treatment response and/or that drive AML-genesis. However, our published and preliminary data reveal that constitutional genetic elements affect not only the frequencies and impact of known AML-associated gene mutations, but also multiple recurrent variants in genes thus-far not implicated in AML-genesis. We hypothesize that: a) known AML-associated drivers may carry different prognostic significance and might need to be adjusted in clinical risk classifications depending on genetic backgrounds, and b) some unrecognized molecular features are novel drivers of AML-genesis and/or therapy resistance. We propose to extend our initial studies of AML genomes and genomics to provide statistical confidence around frequently mutated genes, and a more precise, molecularly-adjusted risk and treatment stratification for AML patients. Next, we will focus on NPM1c, a genotype which currently is predicted to confer favorable outcome in AML patients. We will use cutting-edge single-cell multiomic assays to delineate bystander clonal mutations from potential driver mutations, then we will biologically test their roles in clonality/leukemia-stem-cell frequency and treatment response in genetically heterogeneous patients. We predict this approach to provide an improved characterization of the genetic and genomic landscape of AML, identify those variants with prognostic significance, and provide exemplars of heretofore unrecognized drivers of treatment response and survival. The overall goal is to enable precision oncology approaches which accommodate the effects of underlying human genetics in all patients.




Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortium.
Authors: Peters D.T. , Nicolet D. , Madanat Y.F. , Gonzalez-Lugo J. , Ambinder A. , Chan O. , Foucar C.E. , Sahasrabudhe K.D. , Ameyi J. , Mrózek K. , et al. .
Source: British Journal Of Haematology, 2025-12-03 00:00:00.0; , .
EPub date: 2025-12-03 00:00:00.0.
PMID: 41332326
Related Citations

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).
Authors: Cusan M. , Larkin K. , Nicolet D. , Jurinovic V. , Mrózek K. , Batcha A.M.N. , Rothenberg-Thurley M. , Schneider S. , Sauerland C. , Görlich D. , et al. .
Source: Leukemia, 2025 Dec; 39(12), p. 2926-2934.
EPub date: 2025-09-19 00:00:00.0.
PMID: 40973764
Related Citations

Single cell and spatial transcriptomic profiling of the type 2 diabetic coronary microcirculation and myocardium.
Authors: McCallinhart P.E. , Strawser C.H. , Garfinkle E.A.R. , Navarro J.B. , McAllister C. , Vetter T.A. , Lucchesi P.A. , Mardis E.R. , Mezache L. , Veeraraghavan R. , et al. .
Source: Basic Research In Cardiology, 2025-11-07 00:00:00.0; , .
EPub date: 2025-11-07 00:00:00.0.
PMID: 41203872
Related Citations

Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States.
Authors: Lachowiez C.A. , Asimomitis G. , Bernard E. , Devlin S.M. , Tazi Y. , Creignou M. , Germing U. , Gattermann N. , Gilkes A. , Thomas I. , et al. .
Source: Blood Cancer Discovery, 2025-07-03 00:00:00.0; , .
EPub date: 2025-07-03 00:00:00.0.
PMID: 40608896
Related Citations

Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.
Authors: Sollier E. , Riedel A. , Toprak U.H. , Wierzbinska J.A. , Weichenhan D. , Schmid J.P. , Hakobyan M. , Touzart A. , Jahn E. , Vick B. , et al. .
Source: Blood Cancer Discovery, 2025-07-01 00:00:00.0; 6(4), p. 343-363.
PMID: 40162972
Related Citations

Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.
Authors: Marrero R.J. , Shastri V.M. , Nicolet D. , Mrózek K. , Walker C.J. , Blum W.G. , Powell B.L. , Kolitz J.E. , Moore J.O. , Uy G.L. , et al. .
Source: Jama Network Open, 2025-06-02 00:00:00.0; 8(6), p. e2516296.
EPub date: 2025-06-02 00:00:00.0.
PMID: 40549387
Related Citations

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.
Authors: Mosna F. , Borlenghi E. , Litzow M. , Byrd J.C. , Papayannidis C. , Tecchio C. , Ferrara F. , Marcucci G. , Cairoli R. , Morgan E.A. , et al. .
Source: Haematologica, 2025-03-01 00:00:00.0; 110(3), p. 608-620.
EPub date: 2025-03-01 00:00:00.0.
PMID: 39385741
Related Citations

Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype.
Authors: Leppä A.M. , Grimes K. , Jeong H. , Huang F.Y. , Andrades A. , Waclawiczek A. , Boch T. , Jauch A. , Renders S. , Stelmach P. , et al. .
Source: Nature Genetics, 2024-11-25 00:00:00.0; , .
EPub date: 2024-11-25 00:00:00.0.
PMID: 39587361
Related Citations

Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia.
Authors: Stiff A. , Fornerod M. , Kain B.N. , Nicolet D. , Kelly B.J. , Miller K.E. , Mrózek K. , Boateng I. , Bollas A. , Garfinkle E.A.R. , et al. .
Source: Nature Genetics, 2024-10-04 00:00:00.0; , .
EPub date: 2024-10-04 00:00:00.0.
PMID: 39367245
Related Citations

White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years.
Authors: Ozga M. , Nicolet D. , Mrózek K. , Walker C.J. , Blachly J.S. , Kohlschmidt J. , Orwick S. , Carroll A.J. , Larson R.A. , Kolitz J.E. , et al. .
Source: American Journal Of Hematology, 2024-09-16 00:00:00.0; , .
EPub date: 2024-09-16 00:00:00.0.
PMID: 39283025
Related Citations

An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitors.
Authors: Zhang X. , Song B. , Carlino M.J. , Li G. , Ferchen K. , Chen M. , Thompson E.N. , Kain B.N. , Schnell D. , Thakkar K. , et al. .
Source: Nature Immunology, 2024-03-21 00:00:00.0; , .
EPub date: 2024-03-21 00:00:00.0.
PMID: 38514887
Related Citations

Disparities in acute myeloid leukemia treatments and outcomes.
Authors: Eisfeld A.K. .
Source: Current Opinion In Hematology, 2024-03-01 00:00:00.0; 31(2), p. 58-63.
EPub date: 2023-12-07 00:00:00.0.
PMID: 38059809
Related Citations